Has the PPRS delivered on the aim of reducing bureaucracy and duplication?
Rejection of legal challenge an embarrassing blow, and means NHS England free to introduce new budget curbs.
Keeping the UK branded medicines bill within affordable limits – has PPRS delivered?
Can reducing NHS spending on ‘low-value’ prescriptions help fund new drugs?
A new way to capture when drugs are ‘cost effective’ but not ‘affordable’ looks set to be introduced in England.
Leela Barham examines the approach of the Institute for Clinical and Economic Review.
What could be the impact of proposed new ‘budget impact threshold’ for drugs?
Experts discuss England’s proposed ‘fast-track’ appraisals for new treatments, plus MAAs.
Experts call for urgent development of new drug funding mechanisms.
